Biofrontera AG

€3.02As of Sun 8 Nov 2026, 12:00 UTC
XETRA:B8FKHealthcare
Country Germany
PE (Fwd) •••
TSR 10Y CAGR (25.07%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.51)
PE TTM 3.497
TSR TTM 13.11%
Mkt cap €18.35M
ROIC 7.91%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€3.54
17.28%
45.06%
Hold 2|4|1|4|4
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.04
0.05
0.05
0.06
13.55%
23.73%
32.23%
33.82%
Revenue€M
1.948
1.980
2.076
2.111
8.68%
11.07%
11.01%
11.88%
Peers (US$20.61M)
Cap (US$)
PE
137.0M
2.520x
121.6M
—
73.93M
353.0x
Capital
TTM
5Y
10Y
Leveragex
0.367
(0.019)
(0.018)
EBIT/Intx
0.759
0.464
0.356
Own earn%
(14.28)
(117.44)
(130.86)
Sh yield%
41.14
26.33
25.45
Owners
Insiders/Inst%
10.32
68.76
Short interest%
5.73
SBC / revenue%
3.86
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
28–32
$1 testx
−0.4
Incr. ROIC%
4